Experimental cancer drug trial halted early

NCT ID NCT05159388

Terminated Disease control Sponsor: Servier Bio-Innovation LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new drug called PRS-344/S095012 in people with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and find the right dose. The trial was stopped early, and only 46 people took part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic malignant neoplasm neoplasm Neoplasm Metastasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SOLID TUMOR

Contacts and locations

Locations

Cabrini Oncology Research

Malvern, Victoria, Australia
Carolina Bio Oncology

Huntersville, North Carolina, 28078, United States
Chris O'Brian Lifehouse

Camperdown, Australia
Hospital Universitario Gregorio

Madrid, Spain
Hospital Vall d'Hebron

Barcelona, Spain
Institute Jules Bordet

Brussels, Belgium
NEXT Oncology

San Antonio, Texas, 78229, United States
START

Madrid, 28050, Spain
The Queen Elizabeth Hospital

Woodville South, Australia
U.Z. Gent Medical Oncology

Ghent, Belgium
Universitair Ziekenhuis

Edegem, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.